Brian Wiley Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Brian Wiley.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Brian Wiley. Brian Wiley is a Chief Commercial Officer in NEWLINK GENETICS CORP ($NLNK) and a VP of Business Development in NEWLINK GENETICS CORP ($NLNK).

Address: C/O NEWLINK GENETICS CORPORATION 2503 SOUTH LOOP DRIVE, SUITE 5100 AMES 50010 IA

Companies in which Brian Wiley is an Insider

LUMOS PHARMA, INC.

Trading Symbol: NLNK
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Brian Wiley: Chief Commercial Officer, VP of Business Development
Holdings: 18,753 shares
Current Value: $256,354
Latest Transaction: Mar 13 2018
$NLNK Market Capitalization: $408.17M
$NLNK Previous Close: $13.67

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Brian Wiley

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 13 2018NLNKNEWLINK GENETICS C ...Wiley BrianChief Commercial Of ...Option ExerciseA7.85110,000863,500110,000
Jan 04 2018NLNKNEWLINK GENETICS C ...Wiley BrianChief Commercial Of ...Payment of ExerciseF10.066036,06618,15018.8 K to 18.2 K (-3.22 %)
Jan 04 2018NLNKNEWLINK GENETICS C ...Wiley BrianChief Commercial Of ...Payment of ExerciseF8.471,23710,47718,75320 K to 18.8 K (-6.19 %)
Jan 05 2017NLNKNEWLINK GENETICS C ...Wiley BrianChief Commercial Of ...Option ExerciseA10.5575,000791,25075,000
Jan 05 2017NLNKNEWLINK GENETICS C ...Wiley BrianChief Commercial Of ...Payment of ExerciseF11.046036,65719,27119.9 K to 19.3 K (-3.03 %)
Jan 05 2017NLNKNEWLINK GENETICS C ...Wiley BrianChief Commercial Of ...Payment of ExerciseF10.281,23712,71619,87421.1 K to 19.9 K (-5.86 %)
Aug 11 2016NLNKNEWLINK GENETICS C ...Wiley BrianChief Commercial Of ...Option ExerciseA10.7830,000323,40030,000

View all Brian Wiley insider transactions.